The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Diffusion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 21 shareholders own 9.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.25%	The Vanguard Group, Inc.	66,232	US$437.1k	-8.98%	no data
1.98%	Renaissance Technologies LLC	40,309	US$266.0k	3.07%	no data
1.61%	BlackRock, Inc.	32,852	US$216.8k	0%	no data
0.84%	Geode Capital Management, LLC	17,123	US$113.0k	0%	no data
0.81%	Bridgeway Capital Management, LLC	16,565	US$109.3k	0%	no data
0.3%	Dimensional Fund Advisors LP	6,099	US$40.3k	0%	no data
0.12%	Tower Research Capital LLC	2,410	US$15.9k	-27.4%	no data
0.079%	Robert Cobuzzi	1,616	US$10.7k	0%	no data
0.06%	Jane Hollingsworth	1,231	US$8.1k	0%	no data
0.053%	Mark Giles	1,075	US$7.1k	0%	no data
0.029%	Securities America Advisors, Inc.	587	US$3.9k	0%	no data
0.027%	Morgan Stanley & Co. International Plc Investment Account	548	US$3.6k	0%	no data
0.02%	William Elder	400	US$2.6k	0%	no data
0.014%	Diana Lanchoney	294	US$1.9k	0%	no data
0.0035%	Robert Adams	71	US$468.6	0%	no data
0.0029%	UBS Asset Management AG	60	US$395.9	-87.2%	no data
0.0016%	Alan Levin	33	US$218.1	0%	no data
0.00093%	Osaic Wealth, Inc. , Asset Management Arm	19	US$125.2	0%	no data
0.00074%	Wells Fargo & Company, Private Banking and Investment Banking Arm	15	US$99.6	7.14%	no data
0.00044%	TimeScale Financial, Inc.	9	US$59.2	0%	no data
0.00039%	FSC Securities Corporation, Asset Management Arm	8	US$52.5	0%	no data